Article History
Received: 8 August 2021
Accepted: 1 November 2021
First Online: 10 November 2021
Declarations
:
: All authors (S.H. Jeong, J.H. Jang, and Y.B. Lee) have no conflicts of interest relevant to this study to disclose.
: The study protocol was reviewed and approved by the Institutional Review Board of the Institute of Bioequivalence and Bridging Study, Chonnam National University, Gwangju, Republic of Korea. The bioequivalence study permit numbers were 819; 08.22.2005. Clinical studies were conducted in accordance with the Rules of Good Clinical Practice and the revised Declaration of Helsinki for biomedical research with human subjects.